MCID: CRB006
MIFTS: 41

Cribriform Carcinoma

Categories: Cancer diseases

Aliases & Classifications for Cribriform Carcinoma

MalaCards integrated aliases for Cribriform Carcinoma:

Name: Cribriform Carcinoma 12 14
Ductal Carcinoma, Cribriform Type 12
Carcinoma, Cribriform 69
Carcinoma Cribriform 51

Classifications:



External Ids:

Disease Ontology 12 DOID:5675
MeSH 41 D000230
NCIt 46 C3680
SNOMED-CT 64 30156004
UMLS 69 C0205643

Summaries for Cribriform Carcinoma

MalaCards based summary : Cribriform Carcinoma, also known as ductal carcinoma, cribriform type, is related to benign breast phyllodes tumor and salivary gland adenoid cystic carcinoma. An important gene associated with Cribriform Carcinoma is PGR (Progesterone Receptor), and among its related pathways/superpathways is Gastric cancer. The drugs Fentanyl and Doxepin have been mentioned in the context of this disorder. Affiliated tissues include salivary gland, breast and lung, and related phenotypes are Decreased viability in esophageal squamous lineage and limbs/digits/tail

Related Diseases for Cribriform Carcinoma

Diseases related to Cribriform Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 155)
# Related Disease Score Top Affiliating Genes
1 benign breast phyllodes tumor 29.5 KIT PGR TP63
2 salivary gland adenoid cystic carcinoma 11.0
3 breast angiosarcoma 10.3 KIT PGR
4 uterine body mixed cancer 10.3 KIT PGR
5 cystic nephroma 10.3 KIT PGR
6 perivascular epithelioid cell tumor 10.3 KIT PGR
7 papillary hidradenoma 10.3 KIT PGR
8 vulvar syringoma 10.3 ESR1 PGR
9 vestibular gland benign neoplasm 10.3 ESR1 PGR
10 lung leiomyoma 10.3 ESR1 PGR
11 bartholin's gland adenoma 10.3 ESR1 PGR
12 glassy cell carcinoma of the cervix 10.3 ESR1 PGR
13 vulvar benign neoplasm 10.3 ESR1 PGR
14 dysgerminoma of ovary 10.3 KIT PGR
15 trigonitis 10.3 ESR1 PGR
16 vulvar leiomyoma 10.3 ESR1 PGR
17 uterine carcinosarcoma 10.3 KIT PGR
18 predominantly cortical thymoma 10.3 ESR1 PGR
19 breast medullary carcinoma 10.3 ESR1 PGR
20 breast scirrhous carcinoma 10.3 ESR1 PGR
21 progesterone resistance 10.3 ESR1 PGR
22 progesterone-receptor positive breast cancer 10.3 ESR1 PGR
23 bartholin's gland benign neoplasm 10.3 ESR1 PGR
24 endometrial squamous cell carcinoma 10.3 ESR1 PGR
25 gastric signet ring cell adenocarcinoma 10.3 ESR1 PGR
26 endometrial mucinous adenocarcinoma 10.3 ESR1 PGR
27 deep angioma 10.3 ESR1 PGR
28 gender identity disorder 10.3 ESR1 PGR
29 cervical carcinosarcoma 10.3 ESR1 PGR
30 synchronous bilateral breast carcinoma 10.3 ESR1 PGR
31 intramuscular hemangioma 10.3 ESR1 PGR
32 estrogen excess 10.3 ESR1 PGR
33 mammographic density 10.3 ESR1 PGR
34 retinitis pigmentosa 47 10.3 ESR1 PGR
35 adenomyosis 10.3 ESR1 PGR
36 retinitis pigmentosa 20 10.3 ESR1 PGR
37 luminal breast carcinoma 10.3 ESR1 PGR
38 breast benign neoplasm 10.3 ESR1 PGR
39 thoracic benign neoplasm 10.3 ESR1 PGR
40 cervical clear cell adenocarcinoma 10.3 ESR1 PGR
41 uterine corpus cancer 10.3 ESR1 PGR
42 endometriosis of ovary 10.3 ESR1 PGR
43 muscle cancer 10.3 KIT PGR
44 inflammatory breast carcinoma 10.3 ESR1 PGR
45 lipid-rich carcinoma 10.3 ESR1 PGR
46 reproductive organ benign neoplasm 10.3 ESR1 PGR
47 uterine benign neoplasm 10.3 ESR1 PGR
48 peritoneal mesothelioma 10.3 ESR1 PGR
49 endometritis 10.2 ESR1 PGR
50 prostatic hypertrophy 10.2 ESR1 PGR

Graphical network of the top 20 diseases related to Cribriform Carcinoma:



Diseases related to Cribriform Carcinoma

Symptoms & Phenotypes for Cribriform Carcinoma

GenomeRNAi Phenotypes related to Cribriform Carcinoma according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability in esophageal squamous lineage GR00235-A 9.02 ESR1 KIT KRT7 PGR TP63

MGI Mouse Phenotypes related to Cribriform Carcinoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 limbs/digits/tail MP:0005371 9.62 ESR1 KIT PGR TP63
2 muscle MP:0005369 9.56 ESR1 KIT PGR TP63
3 neoplasm MP:0002006 9.46 ESR1 KIT PGR TP63
4 no phenotypic analysis MP:0003012 9.26 ESR1 KIT PGR TP63
5 renal/urinary system MP:0005367 8.92 ESR1 KIT KRT7 TP63

Drugs & Therapeutics for Cribriform Carcinoma

Drugs for Cribriform Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 161)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Doxepin Approved, Investigational Phase 3 1668-19-5 667468 667477
3
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
4
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
5
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
6
Cevimeline Approved Phase 3 107233-08-9 25137844 83898
7
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
8 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
9
Docetaxel Approved May 1996, Investigational Phase 3,Phase 1,Phase 2 114977-28-5 148124 9877265
10 Liver Extracts Phase 3,Phase 2,Phase 1
11 Alkylating Agents Phase 3,Phase 2,Phase 1
12 Anti-Infective Agents Phase 2, Phase 3,Phase 1
13 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
14 Adjuvants, Anesthesia Phase 3
15 Analgesics Phase 3
16 Analgesics, Opioid Phase 3
17 Anesthetics Phase 3
18 Anesthetics, General Phase 3
19 Anesthetics, Intravenous Phase 3
20 Central Nervous System Depressants Phase 3
21 Narcotics Phase 3
22 Peripheral Nervous System Agents Phase 3
23 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
24 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
25 Mitomycins Phase 3
26 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 1,Phase 2
27 Porfiromycin Phase 3
28 Antidepressive Agents Phase 3
29 Antidepressive Agents, Tricyclic Phase 3
30 Histamine Antagonists Phase 3
31
Histamine Phosphate Phase 3 51-74-1 65513
32 Neurotransmitter Agents Phase 3
33 Psychotropic Drugs Phase 3
34 Antifungal Agents Phase 2, Phase 3,Phase 1
35 Cytochrome P-450 CYP2C9 Inhibitors Phase 2, Phase 3
36 Hormone Antagonists Phase 2, Phase 3
37 Hormones Phase 2, Phase 3,Phase 1
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3
39 Steroid Synthesis Inhibitors Phase 2, Phase 3
40 Autonomic Agents Phase 3
41 Cholinergic Agents Phase 3
42 Antineoplastic Agents, Hormonal Phase 3
43 Appetite Stimulants Phase 3
44 Central Nervous System Stimulants Phase 3
45 Contraceptive Agents Phase 3
46 Contraceptives, Oral Phase 3
47
Megestrol Phase 3 3562-63-8 3080587 19090
48 Antimitotic Agents Phase 3,Phase 2,Phase 1
49 Cola Nutraceutical Phase 3,Phase 2,Phase 1
50
Cetuximab Approved Phase 1, Phase 2 205923-56-4 56842117 2333

Interventional clinical trials:

(show top 50) (show all 111)

# Name Status NCT ID Phase Drugs
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer Completed NCT00002507 Phase 3 mitomycin C;porfiromycin
3 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Completed NCT00765440 Phase 3
4 Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Completed NCT01156142 Phase 3 doxepin hydrochloride
5 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3
6 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00002533 Phase 2, Phase 3 fluconazole
7 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed NCT00017511 Phase 3 cevimeline hydrochloride
8 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Completed NCT00006799 Phase 3 megestrol acetate
9 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Withdrawn NCT00041171 Phase 3 Hypericum perforatum;docetaxel
10 Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck Unknown status NCT00180921 Phase 2 Imatinib
11 Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy Unknown status NCT01192087 Phase 1, Phase 2 Cetuximab
12 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
13 A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Completed NCT00886132 Phase 2 Sunitinib
14 Study of RAD001 in Adenoid Cystic Carcinoma Completed NCT01152840 Phase 2 RAD001
15 Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck Completed NCT00581360 Phase 2 doxorubicin and bortezomib
16 Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Completed NCT01558661 Phase 2 AG-013736 (AXITINIB)
17 Dovitinib in Adenoid Cystic Carcinoma Completed NCT01417143 Phase 2 TKI258 (Dovitinib):
18 Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma Completed NCT01524692 Phase 2 Dovitinib (TKI258)
19 A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Completed NCT01678105 Phase 2 Dovitinib
20 Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck Completed NCT00077428 Phase 2 bortezomib;doxorubicin hydrochloride
21 Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck Completed NCT00017498 Phase 2 gemcitabine hydrochloride
22 Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Completed NCT00095563 Phase 2 lapatinib ditosylate
23 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Completed NCT00045669 Phase 2 imatinib mesylate
24 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
25 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Completed NCT00101348 Phase 1, Phase 2 erlotinib hydrochloride
26 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
27 High-dose ICE With Amifostine Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
28 Docetaxel in Treating Patients With Solid Tumors Completed NCT00003565 Phase 2 docetaxel
29 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Completed NCT00448552 Phase 2 capecitabine;oxaliplatin
30 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Completed NCT00004901 Phase 1, Phase 2 ethynyluracil;fluorouracil;hydroxyurea
31 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Completed NCT00021047 Phase 1, Phase 2 capecitabine;carboplatin;epirubicin hydrochloride
32 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2 DetoxPC
33 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
34 Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor Completed NCT00079079 Phase 2 carboplatin;cisplatin;gemcitabine hydrochloride
35 Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer Completed NCT00004163 Phase 2 Trastuzumab
36 Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery Completed NCT00003744 Phase 2 gemcitabine
37 Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Completed NCT00509665 Phase 2 doxorubicin hydrochloride;gemcitabine hydrochloride
38 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Completed NCT00021333 Phase 2 cisplatin;paclitaxel
39 Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety Recruiting NCT02883374 Phase 2 Chidamide
40 Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma Recruiting NCT03087019 Phase 2 Pembrolizumab
41 A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Recruiting NCT02775370 Phase 2 Apatinib Mesylate
42 Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma Recruiting NCT02859012 Phase 2 Axitinib
43 Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer Recruiting NCT03146650 Phase 2
44 Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer Recruiting NCT03172624 Phase 2 Nivolumab;Ipilimumab
45 Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Recruiting NCT02978625 Phase 2
46 Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies Recruiting NCT03422679 Phase 1, Phase 2 CB-103
47 A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages Recruiting NCT03274414 Phase 2 Cisplatin
48 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Recruiting NCT01806675 Phase 1, Phase 2 fludeoxyglucose F 18;2-fluoropropionyl-labeled pegylated dimeric RGD peptide
49 Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Active, not recruiting NCT02098538 Phase 2 Regorafenib
50 Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma Active, not recruiting NCT02780310 Phase 2 Lenvatinib

Search NIH Clinical Center for Cribriform Carcinoma

Genetic Tests for Cribriform Carcinoma

Anatomical Context for Cribriform Carcinoma

MalaCards organs/tissues related to Cribriform Carcinoma:

38
Salivary Gland, Breast, Lung, Brain, Skin, Liver, Kidney

Publications for Cribriform Carcinoma

Articles related to Cribriform Carcinoma:

(show all 34)
# Title Authors Year
1
GATA-3 staining in primary cutaneous apocrine cribriform carcinoma: usefulness To differentiate it from breast cancer metastasis. ( 29431200 )
2018
2
Role of MRI-targeted Biopsy in Detection of Prostate Cancer Harbouring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma. ( 29408568 )
2018
3
Evaluation and comparison of radiologic-pathologic findings in invasive cribriform carcinoma of the breast. ( 28618754 )
2017
4
Primary Cutaneous Cribriform Carcinoma Treated With Mohs Micrographic Surgery. ( 28872559 )
2017
5
A solid variant of primary cutaneous cribriform carcinoma: a small, stable, long-term lesion. ( 28508756 )
2017
6
Primary Cribriform Carcinoma of the Eyelid With Neuroendocrine Features: A Case Report. ( 28300861 )
2017
7
Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study. ( 26252312 )
2015
8
Primary cutaneous cribriform carcinoma: report of six cases with clinicopathologic data and immunohistochemical profile. ( 25732813 )
2015
9
Invasive cribriform carcinoma of the breast: A report of nine cases and a review of the literature. ( 25789036 )
2015
10
Colonic Cribriform Carcinoma, a Morphologic Pattern Associated With Low Survival. ( 25015669 )
2014
11
Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18a88F-FDG PET-CT features. ( 24938660 )
2014
12
Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. ( 24703897 )
2014
13
Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. ( 23412348 )
2013
14
Cribriform carcinoma mimicking breast abscess - case report. Diagnostic and therapeutic management. ( 26674469 )
2013
15
A pure invasive cribriform carcinoma of the breast with bone metastasis if untreated for thirteen years: a case report and literature review. ( 23167837 )
2012
16
Primary cutaneous cribriform carcinoma of the neck: a case report. ( 23316623 )
2012
17
Invasive cribriform carcinoma arising in malignant phyllodes tumor of breast: a case report. ( 23110003 )
2012
18
Cutaneous cribriform carcinoma: a short comment. ( 21315957 )
2011
19
Sonographic findings of invasive cribriform carcinoma of the breast. ( 21527619 )
2011
20
Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. ( 18724248 )
2008
21
Cribriform carcinoma of the gallbladder: a clinicopathologic study of 7 cases. ( 18769339 )
2008
22
Immunohistochemical phenotype of cutaneous cribriform carcinoma with a panel of 15 antibodies. ( 18085381 )
2007
23
Report on a case of pure cribriform carcinoma of the breast with internal mammary node metastasis: description of the case and review of the literature. ( 16869243 )
2006
24
Primary cutaneous cribriform carcinoma: a rare apocrine tumour. ( 16115058 )
2005
25
Invasive cribriform carcinoma with extensive microcalcifications in the male breast. ( 15858447 )
2005
26
Fine needle aspiration cytology of invasive cribriform carcinoma of the breast with osteoclastlike giant cells: a case report. ( 11480724 )
2001
27
A case report of cribriform carcinoma of the pancreas with long time survival. ( 11268983 )
2001
28
Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. ( 9669346 )
1998
29
Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases. ( 8780923 )
1996
30
Fine needle aspiration of invasive cribriform carcinoma with benign osteoclast-like giant cells of histiocytic origin. A case report. ( 8191846 )
1994
31
The radiological appearances of invasive cribriform carcinoma of the breast. Nottingham Breast Team. ( 7955831 )
1994
32
Light and electron microscopic study of an invasive cribriform carcinoma with extensive microcalcification developing in a breast with silicone augmentation. ( 7810003 )
1994
33
Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. ( 2312110 )
1990
34
Invasive cribriform carcinoma of the breast. ( 6884999 )
1983

Variations for Cribriform Carcinoma

Expression for Cribriform Carcinoma

Search GEO for disease gene expression data for Cribriform Carcinoma.

Pathways for Cribriform Carcinoma

Pathways related to Cribriform Carcinoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.47 ESR1 KIT PGR

GO Terms for Cribriform Carcinoma

Biological processes related to Cribriform Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 steroid hormone mediated signaling pathway GO:0043401 9.32 ESR1 PGR
2 positive regulation of Notch signaling pathway GO:0045747 9.26 KIT TP63
3 stem cell differentiation GO:0048863 9.16 ESR1 KIT
4 epithelial cell development GO:0002064 8.96 ESR1 TP63
5 positive regulation of phospholipase C activity GO:0010863 8.62 ESR1 KIT

Molecular functions related to Cribriform Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ATPase binding GO:0051117 9.32 ESR1 PGR
2 steroid hormone receptor activity GO:0003707 9.26 ESR1 PGR
3 nuclear receptor activity GO:0004879 9.16 ESR1 PGR
4 transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding GO:0001077 9.13 ESR1 PGR TP63
5 steroid binding GO:0005496 8.62 ESR1 PGR

Sources for Cribriform Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....